Medicare Cuts GLP-1 Drug Costs to $50 | Augusta Georgia News

Medicare’s launching a major new trial starting July 26, 2024, that could slash the cost of popular weight-loss drugs to just $50 a month—making them accessible to millions struggling with obesity and related conditions. The Medicare GLP-1 Bridge program, running through 2027, targets those with a BMI of 35+ or lower BMIs with serious health issues like heart disease or kidney problems. It’s a game-changer for affordability, removing a major barrier to life-changing treatments. To qualify, you’ll need a doctor’s prescription for approved GLP-1 drugs and complete prior authorization. This isn’t just a temporary fix—it’s a bold step toward equitable healthcare and could reshape future drug coverage. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/b0416ac6c6dce646